Scientific publications
Revisiting intracavitary immunotherapy of cancer
May 13, 2022
| Magazine: Clinical Cancer Research
Fernando Aranda 1 , Iñaki Eguren-Santamaria 2 , Angela Bella 1 , Pedro Berraondo 1 , Ignacio Melero 3
Abstract
Ovarian cancer is often limited to the peritoneal cavity in the form of peritoneal carcinomatosis. Peritoneal spreading offers the opportunity for locoregional delivery of combinations of immunotherapy agents, maximizing bioavailability while potentially reducing systemic exposure and side effects.
CITATION Clin Cancer Res. 2022 May 13;28(10):1993-1995.
doi: 10.1158/1078-0432.CCR-22-0201.
Our authors
Codirector
Immunology and Immunotherapy Department
Navarre headquarters
Specialist
Medical Oncology Department
Navarre headquarters